Maze Therapeutics, Inc. (MAZE) KPIs and segments

MAZENasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 4/30

$34.33−1.76 (-4.88%)

Close on Nov 13, 2026Market cap $1.91BP/E –Yield –

KPIs & segments

Operating metrics and segments that drive Maze Therapeutics's business

Coming soon

This tab will track the numbers specific to Maze Therapeutics's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.

See a number that looks wrong?